Addressing the Unique Challenges of AD Patients
Patrick Burnett, MD, PhD, FAAD
PeerFDA Approves Ely Lilly’s AD Drug Ebglyss (Lebrikizumab)
ISDPA: Dr. Bhatia on JAK Inhibitors
Neal Bhatia, MD, FAAD
PeerISDPA: Dr. Bhatia and Dr. Zirwas Discuss the Itchy Patient
Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
Collagen in Atopic Dermatitis
Pearls for Monitoring and Managing Itch: An Expert Panel
Talking to Patients About Starting a JAK Inhibitor in Atopic Dermatitis
Andrew Mastro, MS, PA-C
PeerDERM2024: Dr. Friedman on Atopic Dermatitis Diagnosis
Adam Friedman, MD, FAAD
PeerInside LEVEL UP: Lead Investigator Discusses Upadacitinib Study
Jonathan I. Silverberg, MD, PhD, MPH
PeerDermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis Awareness
Alexandra Golant, MD, FAAD
PeerSCALE 2024: Dr. Linda Stein Gold on What’s New and What’s Coming in AD
Linda Stein Gold, MD
PeerPediatric Roundup: Pearls from SDPA Summer Conference 2024
Lisa Swanson, MD, FAAD
PeerDisseminated Varicella Zoster Virus and Herpes Zoster Virus Infection in a Pediatric Patient with Atopic Dermatitis